MAP3K8 (TPL2/COT) affects obesity-induced adipose tissue inflammation without systemic effects in humans and in mice.

Chronic low-grade inflammation in adipose tissue often accompanies obesity, leading to insulin resistance and increasing the risk for metabolic diseases. MAP3K8 (TPL2/COT) is an important signal transductor and activator of pro-inflammatory pathways that has been linked to obesity-induced adipose ti...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Dov B Ballak, Peter van Essen, Janna A van Diepen, Henry Jansen, Anneke Hijmans, Tetsuya Matsuguchi, Helmut Sparrer, Cees J Tack, Mihai G Netea, Leo A B Joosten, Rinke Stienstra
Formato: article
Lenguaje:EN
Publicado: Public Library of Science (PLoS) 2014
Materias:
R
Q
Acceso en línea:https://doaj.org/article/48bc0581a7f04000bf62747d8c6338f4
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:48bc0581a7f04000bf62747d8c6338f4
record_format dspace
spelling oai:doaj.org-article:48bc0581a7f04000bf62747d8c6338f42021-11-18T08:31:19ZMAP3K8 (TPL2/COT) affects obesity-induced adipose tissue inflammation without systemic effects in humans and in mice.1932-620310.1371/journal.pone.0089615https://doaj.org/article/48bc0581a7f04000bf62747d8c6338f42014-01-01T00:00:00Zhttps://www.ncbi.nlm.nih.gov/pmc/articles/pmid/24586913/pdf/?tool=EBIhttps://doaj.org/toc/1932-6203Chronic low-grade inflammation in adipose tissue often accompanies obesity, leading to insulin resistance and increasing the risk for metabolic diseases. MAP3K8 (TPL2/COT) is an important signal transductor and activator of pro-inflammatory pathways that has been linked to obesity-induced adipose tissue inflammation. We used human adipose tissue biopsies to study the relationship of MAP3K8 expression with markers of obesity and expression of pro-inflammatory cytokines (IL-1β, IL-6 and IL-8). Moreover, we evaluated obesity-induced adipose tissue inflammation and insulin resistance in mice lacking MAP3K8 and WT mice on a high-fat diet (HFD) for 16 weeks. Individuals with a BMI >30 displayed a higher mRNA expression of MAP3K8 in adipose tissue compared to individuals with a normal BMI. Additionally, high mRNA expression levels of IL-1β, IL-6 and IL-8, but not TNF -α, in human adipose tissue were associated with higher expression of MAP3K8. Moreover, high plasma SAA and CRP did not associate with increased MAP3K8 expression in adipose tissue. Similarly, no association was found for MAP3K8 expression with plasma insulin or glucose levels. Mice lacking MAP3K8 had similar bodyweight gain as WT mice, yet displayed lower mRNA expression levels of IL-1β, IL-6 and CXCL1 in adipose tissue in response to the HFD as compared to WT animals. However, MAP3K8 deficient mice were not protected against HFD-induced adipose tissue macrophage infiltration or the development of insulin resistance. Together, the data in both human and mouse show that MAP3K8 is involved in local adipose tissue inflammation, specifically for IL-1β and its responsive cytokines IL-6 and IL-8, but does not seem to have systemic effects on insulin resistance.Dov B BallakPeter van EssenJanna A van DiepenHenry JansenAnneke HijmansTetsuya MatsuguchiHelmut SparrerCees J TackMihai G NeteaLeo A B JoostenRinke StienstraPublic Library of Science (PLoS)articleMedicineRScienceQENPLoS ONE, Vol 9, Iss 2, p e89615 (2014)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Dov B Ballak
Peter van Essen
Janna A van Diepen
Henry Jansen
Anneke Hijmans
Tetsuya Matsuguchi
Helmut Sparrer
Cees J Tack
Mihai G Netea
Leo A B Joosten
Rinke Stienstra
MAP3K8 (TPL2/COT) affects obesity-induced adipose tissue inflammation without systemic effects in humans and in mice.
description Chronic low-grade inflammation in adipose tissue often accompanies obesity, leading to insulin resistance and increasing the risk for metabolic diseases. MAP3K8 (TPL2/COT) is an important signal transductor and activator of pro-inflammatory pathways that has been linked to obesity-induced adipose tissue inflammation. We used human adipose tissue biopsies to study the relationship of MAP3K8 expression with markers of obesity and expression of pro-inflammatory cytokines (IL-1β, IL-6 and IL-8). Moreover, we evaluated obesity-induced adipose tissue inflammation and insulin resistance in mice lacking MAP3K8 and WT mice on a high-fat diet (HFD) for 16 weeks. Individuals with a BMI >30 displayed a higher mRNA expression of MAP3K8 in adipose tissue compared to individuals with a normal BMI. Additionally, high mRNA expression levels of IL-1β, IL-6 and IL-8, but not TNF -α, in human adipose tissue were associated with higher expression of MAP3K8. Moreover, high plasma SAA and CRP did not associate with increased MAP3K8 expression in adipose tissue. Similarly, no association was found for MAP3K8 expression with plasma insulin or glucose levels. Mice lacking MAP3K8 had similar bodyweight gain as WT mice, yet displayed lower mRNA expression levels of IL-1β, IL-6 and CXCL1 in adipose tissue in response to the HFD as compared to WT animals. However, MAP3K8 deficient mice were not protected against HFD-induced adipose tissue macrophage infiltration or the development of insulin resistance. Together, the data in both human and mouse show that MAP3K8 is involved in local adipose tissue inflammation, specifically for IL-1β and its responsive cytokines IL-6 and IL-8, but does not seem to have systemic effects on insulin resistance.
format article
author Dov B Ballak
Peter van Essen
Janna A van Diepen
Henry Jansen
Anneke Hijmans
Tetsuya Matsuguchi
Helmut Sparrer
Cees J Tack
Mihai G Netea
Leo A B Joosten
Rinke Stienstra
author_facet Dov B Ballak
Peter van Essen
Janna A van Diepen
Henry Jansen
Anneke Hijmans
Tetsuya Matsuguchi
Helmut Sparrer
Cees J Tack
Mihai G Netea
Leo A B Joosten
Rinke Stienstra
author_sort Dov B Ballak
title MAP3K8 (TPL2/COT) affects obesity-induced adipose tissue inflammation without systemic effects in humans and in mice.
title_short MAP3K8 (TPL2/COT) affects obesity-induced adipose tissue inflammation without systemic effects in humans and in mice.
title_full MAP3K8 (TPL2/COT) affects obesity-induced adipose tissue inflammation without systemic effects in humans and in mice.
title_fullStr MAP3K8 (TPL2/COT) affects obesity-induced adipose tissue inflammation without systemic effects in humans and in mice.
title_full_unstemmed MAP3K8 (TPL2/COT) affects obesity-induced adipose tissue inflammation without systemic effects in humans and in mice.
title_sort map3k8 (tpl2/cot) affects obesity-induced adipose tissue inflammation without systemic effects in humans and in mice.
publisher Public Library of Science (PLoS)
publishDate 2014
url https://doaj.org/article/48bc0581a7f04000bf62747d8c6338f4
work_keys_str_mv AT dovbballak map3k8tpl2cotaffectsobesityinducedadiposetissueinflammationwithoutsystemiceffectsinhumansandinmice
AT petervanessen map3k8tpl2cotaffectsobesityinducedadiposetissueinflammationwithoutsystemiceffectsinhumansandinmice
AT jannaavandiepen map3k8tpl2cotaffectsobesityinducedadiposetissueinflammationwithoutsystemiceffectsinhumansandinmice
AT henryjansen map3k8tpl2cotaffectsobesityinducedadiposetissueinflammationwithoutsystemiceffectsinhumansandinmice
AT annekehijmans map3k8tpl2cotaffectsobesityinducedadiposetissueinflammationwithoutsystemiceffectsinhumansandinmice
AT tetsuyamatsuguchi map3k8tpl2cotaffectsobesityinducedadiposetissueinflammationwithoutsystemiceffectsinhumansandinmice
AT helmutsparrer map3k8tpl2cotaffectsobesityinducedadiposetissueinflammationwithoutsystemiceffectsinhumansandinmice
AT ceesjtack map3k8tpl2cotaffectsobesityinducedadiposetissueinflammationwithoutsystemiceffectsinhumansandinmice
AT mihaignetea map3k8tpl2cotaffectsobesityinducedadiposetissueinflammationwithoutsystemiceffectsinhumansandinmice
AT leoabjoosten map3k8tpl2cotaffectsobesityinducedadiposetissueinflammationwithoutsystemiceffectsinhumansandinmice
AT rinkestienstra map3k8tpl2cotaffectsobesityinducedadiposetissueinflammationwithoutsystemiceffectsinhumansandinmice
_version_ 1718421680188030976